.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Citi
Cipla
AstraZeneca
Teva
Express Scripts
US Army
Cantor Fitzgerald
Deloitte

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074927

« Back to Dashboard
NDA 074927 describes ETODOLAC, which is a drug marketed by Sandoz, Apotex Inc, Mylan Pharms Inc, Teva, Mylan, Apotex, Oxford Pharms, Ani Pharms Inc, Ranbaxy Labs Ltd, Eci Pharms Llc, Watson Labs Florida, Zydus Pharms Usa Inc, Idt Australia Ltd, Chartwell Molecules, Watson Labs, Taro, Taro Pharm Inds, Ivax Sub Teva Pharms, and Actavis Elizabeth, and is included in thirty-three NDAs. It is available from thirty-seven suppliers. Additional details are available on the ETODOLAC profile page.

The generic ingredient in ETODOLAC is etodolac. There are twenty-two drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the etodolac profile page.

Summary for NDA: 074927

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength400MG
Approval Date:Oct 30, 1997TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Colorcon
Argus Health
Moodys
US Army
Mallinckrodt
Boehringer Ingelheim
US Department of Justice
Julphar
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot